Guillermo A. Escobar

ORCID: 0000-0001-6771-9472
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aortic aneurysm repair treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Vascular Procedures and Complications
  • Aortic Disease and Treatment Approaches
  • Venous Thromboembolism Diagnosis and Management
  • Infectious Aortic and Vascular Conditions
  • Peripheral Artery Disease Management
  • Central Venous Catheters and Hemodialysis
  • Cerebrovascular and Carotid Artery Diseases
  • Diversity and Career in Medicine
  • Abdominal vascular conditions and treatments
  • Renal and Vascular Pathologies
  • Vascular anomalies and interventions
  • Healthcare professionals’ stress and burnout
  • Immune Response and Inflammation
  • Global Health Workforce Issues
  • Orthopaedic implants and arthroplasty
  • Innovations in Medical Education
  • Intracranial Aneurysms: Treatment and Complications
  • Diagnosis and Treatment of Venous Diseases
  • Human Rights and Immigration
  • Body Contouring and Surgery
  • Reconstructive Surgery and Microvascular Techniques
  • Medical Education and Admissions
  • Atrial Fibrillation Management and Outcomes

Emory University
2017-2025

Emory University Hospital
2021-2023

University at Buffalo, State University of New York
2020

Washington University in St. Louis
2020

Central Michigan University
2020

Michigan State University
2020

Christiana Care Health System
2020

National University of Singapore
2020

University of Washington
2020

Penn State Milton S. Hershey Medical Center
2020

Model systems demonstrate that progression to ESRD is driven by progressive podocyte depletion (the hypothesis) and can be noninvasively monitored through measurement of urine pellet mRNAs. To test these concepts in humans, we analyzed mRNAs from 358 adult pediatric kidney clinic patients 291 controls (n=1143 samples). Compared with controls, increased 79-fold (P<0.001) biopsy-proven glomerular disease a 50% decrease function or ESRD. An independent cohort Alport syndrome had 23-fold...

10.1681/asn.2013020173 article EN Journal of the American Society of Nephrology 2013-09-20
Susan R. Kahn Jim A. Julian Clive Kearon Chu‐Shu Gu David J. Cohen and 95 more Elizabeth A. Magnuson Anthony J. Comerota Samuel Z. Goldhaber Michael R. Jaff Mahmood K. Razavi Andrei Kindzelski Joseph R. Schneider Paul S. Kim Rabih A. Chaer Akhilesh K. Sista Robert B. McLafferty John A. Kaufman Brandt C. Wible Morey A. Blinder Suresh Vedantham Michael J. Sichlau Athanasios Vlahos Steven J. Smith Quinn Thalheimer Nisha Singh Rekha Harting John Gocke Scott Guth Neel Shah Paul S. Brady Marvin Schatz Mindy M. Horrow Peyman Markazi Leli Forouzan Terence A.S. Matalon D. W. Hertzog Swapna Goday Margaret Kennedy Robert M. Kaplan Thomas Campbell Jamie Hartman Elmer Nahum Arvind Venkat Venkataramu N. Krishnamurthy John Rectenwald Peter K. Henke Jonathan L. Eliason Jonathon Willatt Guillermo A. Escobar Shaun Samuels Barry T. Katzen James F. Benenati Alex Powell Constantino Peña Howard W. Wallach Ripal Gandhi Joseph R. Schneider Stanley E. Kim F Amouzegar Hashemi Joseph J. Boyle Nilesh Patel Michael J. Verta Daniel A. Leung M. Llopis García Phillip Blatt Jamil Khatri Dave Epstein Randall E. Ryan Tom Sweeny Michael Stillabower G. Kimbiris Tuhina Raman Paul Sierzenski Lelia Getto Michael Dignazio Paul Sierzenski Márk Horváth Heather L. Gornik John R. Bartholomew Mehdi H. Shishehbor Frank Peacock Douglas Joseph Soo Hyum Kim Natalia Fendrikova Mahlay Daniel G. Clair Sean P. Lyden Baljendra Kapoor Gordon McLennon Gregory Pierce James R. Newman James Andrew Spain Amanjiit Gill Aaron Hamilton Anthony Rizzo Woosup Park Alan M. Dietzek Ira Galin Dahlia Plummer Richard Hsu Patrick Broderick

10.1016/j.jvsv.2019.03.023 article EN publisher-specific-oa Journal of Vascular Surgery Venous and Lymphatic Disorders 2019-12-13

In Brief Summary Background Data: The transfusion of more than 6 units packed red blood cells (PRBCs) within the first 12 hours injury is strongest independent predictor multiple organ failure (MOF). This suggests that stored contains bioactive factors may modify immunoinflammatory response. Methods: To simulate postinjury major transfusions ex vivo, we obtained whole from 4 healthy adults and divided it into four 7-mL groups (I–IV). Group I was not diluted. II had 7 mL 0.9% sterile saline...

10.1097/01.sla.0000264507.79859.f9 article EN Annals of Surgery 2007-06-21

Objective: Our goal was to assess the outcomes of females compared males treated with endovascular lower extremity interventions in order determine optimal therapy based on gender. Methods: We performed a retrospective review evaluating primary transluminal angioplasty (PTA) and PTA + stenting (PTA S) for peripheral arterial disease (PAD). Patency rates limb salvage were end points. Results: A total 1017 lesions analyzed 537 patients (229 male 308 female) between 2004 2009. There no...

10.1177/1538574411418008 article EN Vascular and Endovascular Surgery 2011-09-13

Given the very ill nature of patients with critical limb ischemia (CLI), use percutaneous vascular interventions (PVIs) for salvage may or not be efficacious; in particular, those polyvascular arterial disease. Herein, we reviewed large, multi-institutional outcomes PVI and peripheral disease (PAD) CLI. An 18-hospital consortium collected prospective data on undergoing endovascular PAD 6-month follow-up from January 2008 to December 2011. The patient cohort included 4459 CLI; those, 3141 had...

10.1177/1358863x14552013 article EN Vascular Medicine 2014-10-07

Abstract Background Non-islet cell tumor induced hypoglycemia (NICTH) is a very rare phenomenon, but even more so in gastrointestinal stromal tumors. It tends to present large or metastatic tumors, and can appear at any time the progression of disease. We herein case NICTH GIST report an exon 9 mutation associated it. Case presentation A thirty nine year-old man with recurrent, presented hospital nausea, dizziness, loss consciousness, profound (20 mg/dL). There was no evidence factitious...

10.1186/1471-2407-7-13 article EN cc-by BMC Cancer 2007-01-17
Coming Soon ...